Home LiteratureArticle Details
PMID: 9557638 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interaction of poliovirus with its purified receptor and conformational alteration in the virion.

Journal of virology ·Vol. 72 ·No. 5 ·1998-05-00 ·Pages 3578-86

Arita M, Koike S, Aoki J, Horie H, Nomoto A

Abstract

Polypeptides of amino acids 1 to 241 (PVR241) and 1 to 330 (PVR330) of the human poliovirus receptor (hPVR) were produced in a baculovirus expression system. PVR241 contained extracellular domains 1 and 2 of hPVR, and PVR330 contained extracellular domains 1, 2, and 3. These peptides were purified by immunoaffinity column chromatography with an anti-hPVR monoclonal antibody (MAb). After the purification, PVR241 and PVR330 appeared to retain their native conformation as judged by reactivity with an anti-PVR MAb that recognized domain 1 of hPVR in a conformation-dependent manner. The virulent Mahoney strain of poliovirus type 1 was mixed with the purified PVRs in various concentrations. An average of at least 43 PVR330 molecules were able to bind to one virion particle under the conditions used. The equilibrium dissociation constant between the PVR330 molecule and the PVR binding site (canyon) on the virion was determined to be 4.50 +/- (0.86) x 10(-8) M at 4 degrees C. Higher rates of conformational change of the virus (160S) to 135S and 80S particles were observed as the concentration of PVR330 was increased. In this in vitro system, the ratio of the amount of the 135S particle to that of the 80S particle seemed to be always constant. After the disappearance of the 160S particle, the amount of the 80S particle was not increased by further incubation at 37 degrees C. These results suggested that the 80S particle was not derived from the 135S particle under the conditions used in this study.

MeSH Terms
Animals Binding Sites Bombyx Cell Line Centrifugation, Density Gradient Chemical Fractionation HeLa Cells Humans Kinetics Membrane Proteins Poliovirus/metabolism,ultrastructure Receptors, Virus/genetics,isolation & purification,metabolism Recombinant Fusion Proteins/genetics,isolation & purification,metabolism Virion/metabolism,ultrastructure
Chemicals
Membrane Proteins Receptors, Virus Recombinant Fusion Proteins poliovirus receptor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Arita M
Institute of Medical Science, The University of Tokyo, Japan.
Koike S
Aoki J
Horie H
Nomoto A
References (42)
42 references, click to expand
  1. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  2. Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3598-602 PMID: 1673787
  3. Studies on the in vitro uncoating of poliovirus. I. Characterization of the modifying factor and the modifying reaction.
    Virology. 1976 Apr;70(2):470-83 PMID: 4921
  4. Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle.
    Virology. 1977 May 15;78(2):554-66 PMID: 194397
  5. A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay.
    Virology. 1977 Oct 1;82(1):25-36 PMID: 197703
  6. Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose.
    Dev Biol Stand. 1979;42:75-80 PMID: 223925
  7. Studies on the in vitro uncoating of poliovirus. III. Roles of membrane-modifying and -stabilizing factors in the generation of subviral particles.
    Virology. 1980 Jul 15;104(1):149-63 PMID: 6249022
  8. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
    J Virol. 1985 Mar;53(3):786-92 PMID: 2983090
  9. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
    Vaccine. 1983 Dec;1(1):17-22 PMID: 6099638
  10. Structure of a human common cold virus and functional relationship to other picornaviruses.
    Nature. 1985 Sep 12-18;317(6033):145-53 PMID: 2993920
  11. Three-dimensional structure of poliovirus at 2.9 A resolution.
    Science. 1985 Sep 27;229(4720):1358-65 PMID: 2994218
  12. Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain.
    Virology. 1985 Apr 30;142(2):307-16 PMID: 2997988
  13. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    J Virol. 1989 Mar;63(3):1302-9 PMID: 2536835
  14. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.
    Cell. 1989 Mar 10;56(5):855-65 PMID: 2538245
  15. Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
    J Virol. 1990 May;64(5):1934-45 PMID: 2157861
  16. Neutralization of poliovirus by cell receptors expressed in insect cells.
    J Virol. 1990 Oct;64(10):4697-702 PMID: 2168959
  17. The poliovirus receptor protein is produced both as membrane-bound and secreted forms.
    EMBO J. 1990 Oct;9(10):3217-24 PMID: 2170108
  18. Immunoelectron microscopy on the topographical distribution of the poliovirus receptor.
    J Gen Virol. 1990 Nov;71 ( Pt 11):2737-40 PMID: 2174964
  19. Cleavage site of the poliovirus receptor signal sequence.
    J Gen Virol. 1994 Aug;75 ( Pt 8):1875-81 PMID: 8046389
  20. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.
    Virology. 1994 Sep;203(2):344-56 PMID: 7914388
  21. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.
    EMBO J. 1994 Dec 15;13(24):5855-62 PMID: 7813425
  22. Functional domains of the poliovirus receptor.
    Proc Natl Acad Sci U S A. 1991 May 15;88(10):4104-8 PMID: 1851992
  23. Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.
    J Virol. 1991 Nov;65(11):6015-23 PMID: 1681115
  24. A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells.
    J Virol. 1992 Apr;66(4):2523-6 PMID: 1312641
  25. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene.
    J Virol. 1992 May;66(5):2807-13 PMID: 1560525
  26. The soluble form of two N-terminal domains of the poliovirus receptor is sufficient for blocking viral infection.
    Virus Res. 1992 Sep 1;25(1-2):51-61 PMID: 1329376
  27. A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain.
    J Virol. 1992 Dec;66(12):7059-66 PMID: 1331508
  28. N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor.
    J Virol. 1992 Dec;66(12):7368-73 PMID: 1331527
  29. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
    J Virol. 1993 Jan;67(1):390-7 PMID: 8093221
  30. Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli.
    Antimicrob Agents Chemother. 1993 Jun;37(6):1278-84 PMID: 8101071
  31. Characterization of poliovirus conformational alteration mediated by soluble cell receptors.
    Virology. 1993 Nov;197(1):501-5 PMID: 8212594
  32. Molecular characterization of the cellular receptor for poliovirus.
    Virology. 1994 Feb 15;199(1):105-13 PMID: 8116232
  33. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus.
    J Biol Chem. 1994 Mar 18;269(11):8431-8 PMID: 8132569
  34. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication.
    J Virol. 1994 Apr;68(4):2578-88 PMID: 8139037
  35. Interaction of poliovirus with its cell surface binding site.
    Virology. 1994 May 15;201(1):107-15 PMID: 8178474
  36. A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.
    J Virol. 1995 Nov;69(11):6825-32 PMID: 7474095
  37. How to measure and predict the molar absorption coefficient of a protein.
    Protein Sci. 1995 Nov;4(11):2411-23 PMID: 8563639
  38. The poliovirus 135S particle is infectious.
    J Virol. 1996 Oct;70(10):7125-31 PMID: 8794359
  39. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
    Virology. 1997 Mar 17;229(2):421-8 PMID: 9126254
  40. Cold-adapted poliovirus mutants bypass a postentry replication block.
    J Virol. 1997 Jun;71(6):4728-35 PMID: 9151866
  41. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.
    Exp Cell Res. 1997 Sep 15;235(2):374-84 PMID: 9299162
  42. Early alteration of poliovirus in infected cells and its specific inhibition.
    J Gen Virol. 1975 Jun;27(3):329-42 PMID: 167116
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-05-00
Pages
3578-86
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC109578
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com